HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.

Abstract
Systemic amyloidosis with hepatic involvement is a rare disorder, which is characterized by the deposits of amyloid fibrils in the liver. The prognosis is poor and the median survival is 13 months. Bleeding problems resulting from coagulopathy frequently complicates systemic amyloidosis. We present two patients with a severe factor X deficiency and hepatomegaly as the presenting abnormalities of systemic amyloidosis. One of the patients was treated with high dose melphalan chemotherapy and autologous stem cell reinfusion, resulting in a normalization of the liver enzyme tests and the factor X level. The diagnosis and treatment of systemic amyloidosis with hepatic involvement and the management of the multifactorial coagulopathy in these cases is discussed.
AuthorsDimitri A Breems, Pieter Sonneveld, Rob A de Man, Frank W G Leebeek
JournalEuropean journal of haematology (Eur J Haematol) Vol. 72 Issue 3 Pg. 181-5 (Mar 2004) ISSN: 0902-4441 [Print] England
PMID14962236 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dexamethasone
  • Doxorubicin
  • Factor X
  • gamma-Glutamyltransferase
  • Alkaline Phosphatase
  • Melphalan
Topics
  • Alkaline Phosphatase (blood)
  • Amyloidosis (complications, drug therapy, metabolism, therapy)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Blood Coagulation Disorders (etiology)
  • Blood Coagulation Tests
  • Dexamethasone (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Factor X (metabolism)
  • Factor X Deficiency (blood, drug therapy, etiology, therapy)
  • Hepatomegaly (blood, etiology, therapy)
  • Humans
  • Male
  • Melphalan (administration & dosage, therapeutic use)
  • Middle Aged
  • Stem Cell Transplantation (methods)
  • Transplantation, Autologous
  • Treatment Outcome
  • gamma-Glutamyltransferase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: